Lexicon Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · The Woodlands, TX
LXRX chart
What traders are saying about $LXRX
Latest postsLexicon Pharmaceuticals, Inc. news
- Lexicon Pharmaceuticals, Inc. (LXRX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Lexicon Pharmaceuticals, Inc. Estimates – NASDAQ:LXRX
TradingView ·
- Lexicon Pharmaceuticals, Inc. (LXRX) stock price, news, quote and history
Yahoo Finance UK ·
- Lexicon Pharmaceuticals Provides Update on Baseline Patient Characteristics for Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Hypertrophic Cardiomyopathy
Yahoo Finance ·
- People in a heart muscle disease trial averaged 59 on a 100-point symptom score, showing substantial symptoms.
Stock Titan ·
- Lexicon Pharmaceuticals stock: Cantor keeps USD 8.00 target for Lexicon Pharmaceuticals stock
ad-hoc-news.de ·
- Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease
Yahoo Finance ·
- Cantor Fitzgerald Reaffirms Their Buy Rating on Lexicon Pharmaceuticals (LXRX)
The Globe and Mail ·
- Lexicon Pharmaceuticals (LXRX) Stock Fair Value Rises After SONATA HCM Trial Progress
Yahoo Finance ·
- Why Lexicon Pharmaceuticals Stock Popped by Almost 6% Today
fool.com ·
- Lexicon Pharmaceuticals surges as Cantor Fitzgerald sees unencumbered path in HCM
Yahoo Finance ·
- LX-9211 Market Outlook 2026-2034 | Sales Forecast Highlights Emerging Commercial Opportunities
Yahoo Finance ·
Lexicon Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $6.0M | $1.1M | $0 |
| Net income | -$50.3M | -$200.4M | -$177.1M | -$101.9M |
| Diluted EPS | $-0.14 | $-0.63 | $-0.80 | $-0.62 |
| Total assets (year end) | $185.0M | $298.4M | $229.4M | $194.3M |
| Cash and equivalents (year end) | $34.3M | $66.7M | $22.5M | $46.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lexicon Pharmaceuticals, Inc.
- Ticker
- LXRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- The Woodlands, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1062822
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Frequently asked questions
What exchange is Lexicon Pharmaceuticals, Inc. listed on?
Lexicon Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol LXRX.
What industry is Lexicon Pharmaceuticals, Inc. in?
Lexicon Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Lexicon Pharmaceuticals, Inc. headquartered?
Lexicon Pharmaceuticals, Inc.'s business address on file with the SEC is in The Woodlands, TX.
When does Lexicon Pharmaceuticals, Inc.'s fiscal year end?
Lexicon Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Lexicon Pharmaceuticals, Inc. report?
Lexicon Pharmaceuticals, Inc. reported $6.0M in revenue for calendar year 2024, according to its SEC filings.